Health
Vaccine wars escalate as new antibody escape variants raise the bar – Medical Xpress
When a new mutation within the SARS-CoV-2 spike protein receptor binding domain (RBD) emerges that a particular antibody can no longer neutralyze, it is often called…
When a new mutation within the SARS-CoV-2 spike protein receptor binding domain (RBD) emerges that a particular antibody can no longer neutralyze, it is often called an escape variant. With the rapid identification of these new variants within the infected population, and also in lab-generated versions of the spike protein, an exhaustive escape variant matrix has begun to take shape. The good news is that as long as the actual antibody responses of vaccinated individuals are tested and verified,…
-
Business17 hours agoCould a small investor today match the historic returns of Warren Buffett?
-
Business11 hours agoAustralian rare earths companies trading at record levels as China tightens export controls
-
Business9 hours agoWhat’s Macquarie’s price target on Mineral Resources shares?
-
Noosa News22 hours agoHomicide investigation, Torquay – Sunshine Coast